udenafil

Known as: 3-(1-methyl-7-oxo-3-propyl-4,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-{2-[(2RS)-1-methylpyrrolidin-2-yl]ethyl}-4-propoxybenzenesulfonamide, 5-(2-propyloxy-5-(1-methyl-2-pyrollidinylethylamidosulfonyl)phenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo (4,3-d) pyrimidine-7-one, Benzenesulfonamide, 3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-4-propoxy- 
A benzenesulfonamide derivative with vasodilatory activity. Udenafil selectively inhibits phosphodiesterase type 5 (PDE5), thus inhibiting the… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Erectile dysfunction (ED) is often perceived by both patients and sexual partners as a serious problem that can jeopardize… (More)
  • figure 1
  • table 2
Is this relevant?
2013
2013
We report a 67-year-old man who presented with severe headache after taking 50 mg of udenafil, a new phosphodiesterase 5… (More)
Is this relevant?
2012
2012
To achieve rapid onset of action and improved bioavailability of udenafil, a microemulsion system was developed for its… (More)
  • table 1
  • table 2
  • table 3
  • figure 3
  • figure 4
Is this relevant?
2011
2011
Pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives are new chemical entities with good and attractive… (More)
  • table 1
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2011
2011
The synthesis and SAR of a series of novel pyrazolo-quinazolines as potent and selective MPS1 inhibitors are reported. We… (More)
Is this relevant?
2008
2008
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT The phosphodiesterase (PDE) type 5 inhibitor is a widely used agent that facilitates… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2008
2008
INTRODUCTION Udenafil is a potent selective phosphodiesterase type 5 (PDE5) inhibitor newly developed for the treatment of… (More)
Is this relevant?
Review
2006
Review
2006
Udenafil is an oral PDE5 inhibitor that is currently available in South Korea for the treatment of erectile dysfunction (ED… (More)
Is this relevant?
Review
1998
Review
1998
Sildenafil citrate, an oral therapy for erectile dysfunction, is a selective inhibitor of cyclic guanosine monophosphate (cGMP… (More)
Is this relevant?
1996
1996
1. In rat aortic rings precontracted with phenylephrine, the beta-adrenoceptor agonist isoprenaline (10 nM to 30 microM) produces… (More)
Is this relevant?